Clinical Trials · NCT03630666

Comparison of Intermittent Androgen Deprivation Therapy With or Without Irradiation Recovery in Prostate Cancer Patients

Active Not RecruitingN/AGonadorelin (Investigational)
Phase
N/A
Recruitment status
Active Not Recruiting
Sponsor
Institut Cancerologie de l'Ouest
Enrollment
256
Start date
Dec 2018
Locations
16 sites, France
Primary endpoint
progression-free survival
View Gonadorelin compound reference